Latest news

uMotif and Xperiome collaborate to bring studies to rare disease patients more quickly and effectively

Leading clinical technology providers join forces to tackle key clinical trial pain point, powering efforts to improve patient recruitment and retention in rare disease research studies

Science 37® and Xperiome™ Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers

Using Science 37’s decentralized clinical trials model, the partnership offers Xperiome’s research-ready, rare disease patients more study opportunities, with less burden.

Healthtech company Raremark® reboots as Xperiome™ to drive increased value for rare disease patients and researchers

In response to the exceptional growth we’re experiencing, both within the patient community and the commercial pharma environment, we are rebranding as Xperiome.

Global rare disease specialist Raremark® appoints healthtech trailblazer Dale Jessop as new CTO

Healthtech trailblazer Dale Jessop joins Raremark as CTO to direct the company’s data-driven strategy for technology

Caroline O’Connor becomes new CCO of rare disease healthtech Raremark® amid rapid growth

Raremark names Caroline O'Connor as its new Chief Commercial Officer to take ownership of the company’s commercial focus

Prime Global and Raremark® form strategic partnership to transform solutions and outcomes for patients with rare diseases

The expertise and heritage of two award-winning companies have been brought together to form a strategic partnership with patient outcomes at the heart

Get in touch

Interested in hearing more? Feel free to reach out to us, and we’ll make sure to get back to you as soon as possible.